This topic contains a solution. Click here to go to the answer

Author Question: Minuchin refers to the family as a(n): a. ego mass. b. open system. c. social learning ... (Read 28 times)

daltonest1984

  • Hero Member
  • *****
  • Posts: 536
Minuchin refers to the family as a(n):
 
  a. ego mass.
  b. open system.
  c. social learning environment
  d. organization with subsystemsBehavior that is typical of family members who are overinvolved or protective is called _______________beha vior.
 a. paradoxical
  b. disengaged
  c. enmeshed
  d. reciprocal

Question 2

When a family member fails to attend therapy the therapist should ask the following:
 
  a. Have I acknowledged the fears of the clients?
  b. Have I reassured the client how I can orchestrate a constructive outcome when others are included?
  c. a and b.
  d. none of the above.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Eunice618

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

.C

Answer to Question 2

.C




daltonest1984

  • Member
  • Posts: 536
Reply 2 on: Jun 19, 2018
Great answer, keep it coming :)


tandmlomax84

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library